4//SEC Filing
MANHARD KIMBERLY 4
Accession 0000950142-24-001494
CIK 0002007919other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 6:11 PM ET
Size
5.9 KB
Accession
0000950142-24-001494
Insider Transaction Report
Form 4
MANHARD KIMBERLY
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-30+30,000→ 30,000 totalExercise: $15.86Exp: 2034-05-30→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This stock option was granted following the consummation of the merger of Inhibrx, Inc. with a wholly owned indirect subsidiary of Sanofi.
- [F2]This stock option will be fully exercisable on May 30, 2025, subject to the reporting person's continued service through such date.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeother
Related Parties
1- filerCIK 0001202094
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 6:11 PM ET
- Size
- 5.9 KB